Skip to main content
Top
Published in: Diabetologia 5/2011

01-05-2011 | Article

Risk stratification systems for diabetic foot ulcers: a systematic review

Authors: M. Monteiro-Soares, E. J. Boyko, J. Ribeiro, I. Ribeiro, M. Dinis-Ribeiro

Published in: Diabetologia | Issue 5/2011

Login to get access

Abstract

Aims/hypothesis

Several risk stratification systems have been proposed for predicting development of diabetic foot ulcer. However, little has been published that assesses their similarities and disparities, diagnostic accuracy and evidence level. Consequently, we conducted a systematic review of the existing stratification systems.

Methods

We searched the MEDLINE database for studies (published until April 2010) describing the creation and validation of risk stratification systems for prediction of diabetic foot ulcer development.

Results

We included 13 studies describing or evaluating the following different risk degree stratification systems: University of Texas; International Working Group on Diabetic Foot; Scottish Intercollegiate Guideline Network (SIGN); American Diabetes Association; and Boyko and colleagues. We confirmed that five variables were included in almost all the systems: diabetic neuropathy, peripheral vascular disease, foot deformity, and previous foot ulcer and amputation. The number of variables included ranged from four to eight and the number of risk groups from two to six. Only four studies reported or allowed the calculation of diagnostic accuracy measures. The SIGN system showed some higher diagnostic accuracy values, particularly positive likelihood ratio, while predictive ability was confirmed through external validation only in the system of Boyko et al.

Conclusions/interpretation

Foot ulcer risk stratification systems are a much needed tool for screening patients with diabetes. The core variables of various systems are very similar, but the number of included variables in each model and risk groups varied greatly. Overall, the quality of evidence for these systems is low, as little validation of their predictive ability has been done.
Literature
1.
go back to reference Fard AS, Esmaelzadeh M, Larijani B (2007) Assessment and treatment of diabetic foot ulcer. Int J Clin Pract 61:1931–1938PubMedCrossRef Fard AS, Esmaelzadeh M, Larijani B (2007) Assessment and treatment of diabetic foot ulcer. Int J Clin Pract 61:1931–1938PubMedCrossRef
2.
go back to reference Khanolkar MP, Bain SC, Stephens JW (2008) The diabetic foot. Q J Med 101:685–695 Khanolkar MP, Bain SC, Stephens JW (2008) The diabetic foot. Q J Med 101:685–695
3.
go back to reference Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab Care 27:1047–1053CrossRef Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diab Care 27:1047–1053CrossRef
4.
go back to reference Frykberg RG, Zgnois T, Armstrong DG et al (2006) Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg 45(Suppl 5):S1–S66PubMedCrossRef Frykberg RG, Zgnois T, Armstrong DG et al (2006) Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg 45(Suppl 5):S1–S66PubMedCrossRef
5.
go back to reference Leese G, Schofield C, McMurray B et al (2007) Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic. Diab Care 30:2064–2069CrossRef Leese G, Schofield C, McMurray B et al (2007) Scottish foot ulcer risk score predicts foot ulcer healing in a regional specialist foot clinic. Diab Care 30:2064–2069CrossRef
6.
7.
go back to reference Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi Lecture. Diabetologia 47:1343–1353PubMedCrossRef Boulton AJ (2004) The diabetic foot: from art to science. The 18th Camillo Golgi Lecture. Diabetologia 47:1343–1353PubMedCrossRef
8.
go back to reference Larsson J, Agardh CD, Apelqvist J, Stenström A (1998) Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 350:149–158PubMedCrossRef Larsson J, Agardh CD, Apelqvist J, Stenström A (1998) Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res 350:149–158PubMedCrossRef
9.
go back to reference Apelqvist J, Bakker K, van Houtum WH, for the International Working Group on Diabetic Foot et al (2000) International consensus and practical guidelines on the management and the prevention of the diabetic foot. Diabetes Metab Res Rev 16(Suppl 1):S84–S92PubMedCrossRef Apelqvist J, Bakker K, van Houtum WH, for the International Working Group on Diabetic Foot et al (2000) International consensus and practical guidelines on the management and the prevention of the diabetic foot. Diabetes Metab Res Rev 16(Suppl 1):S84–S92PubMedCrossRef
10.
go back to reference Boulton AJ, Meneses P, Ennis W (1999) Diabetic foot ulcers: a framework for prevention and care. Wound Repair Regen 7:7–16PubMedCrossRef Boulton AJ, Meneses P, Ennis W (1999) Diabetic foot ulcers: a framework for prevention and care. Wound Repair Regen 7:7–16PubMedCrossRef
11.
go back to reference Boulton AJ, Armstrong DG, Albert SF et al (2008) Comprehensive foot examination and risk assessment—a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association with endorsement by the American Diabetes Association of Clinical Endocrinologists. Diab Care 31:1679–1685CrossRef Boulton AJ, Armstrong DG, Albert SF et al (2008) Comprehensive foot examination and risk assessment—a report of the Task Force of the Foot Care Interest Group of the American Diabetes Association with endorsement by the American Diabetes Association of Clinical Endocrinologists. Diab Care 31:1679–1685CrossRef
12.
go back to reference Boulton AJ, Armstrong DG, Albert SF et al (2008) Comprehensive foot examination and risk assessment. Endocr Pract 14:576–583PubMed Boulton AJ, Armstrong DG, Albert SF et al (2008) Comprehensive foot examination and risk assessment. Endocr Pract 14:576–583PubMed
13.
go back to reference Helfand AE, Hirt PR (1994) Caring for the diabetic: assessing the risk in the diabetic foot. N J Med 91:256–258PubMed Helfand AE, Hirt PR (1994) Caring for the diabetic: assessing the risk in the diabetic foot. N J Med 91:256–258PubMed
14.
go back to reference Apelqvist J, Bakker K, van Houtum WH, Schaper NC, International Working Group on the Diabetic Foot (IWGDF) Editorial Board (2008) Practical guidelines on the management and prevention of the diabetic foot—based upon the International Consensus on the Diabetic Foot (2007). Diabetes Metab Res Rev 24(Suppl 1):S18–S187 Apelqvist J, Bakker K, van Houtum WH, Schaper NC, International Working Group on the Diabetic Foot (IWGDF) Editorial Board (2008) Practical guidelines on the management and prevention of the diabetic foot—based upon the International Consensus on the Diabetic Foot (2007). Diabetes Metab Res Rev 24(Suppl 1):S18–S187
15.
go back to reference Bower VM, Hobbs M (2009) Validation of the basic foot screening checklist. A population screening tool for identifying foot ulcer risk in people with diabetes mellitus. J Am Podiatr Med Assoc 99:339–347PubMed Bower VM, Hobbs M (2009) Validation of the basic foot screening checklist. A population screening tool for identifying foot ulcer risk in people with diabetes mellitus. J Am Podiatr Med Assoc 99:339–347PubMed
16.
go back to reference Vandenbrouke JP, von Elm E, Altman DG, STROBE initiative et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 147:W163–W194 Vandenbrouke JP, von Elm E, Altman DG, STROBE initiative et al (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Ann Intern Med 147:W163–W194
17.
go back to reference Bossuyt PM, Reistma JB, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138:W1–W12PubMed Bossuyt PM, Reistma JB, Bruns DE et al (2003) The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 138:W1–W12PubMed
18.
go back to reference Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG (1998) Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 158:157–162PubMedCrossRef Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG (1998) Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 158:157–162PubMedCrossRef
19.
go back to reference Peters EJ, Lavery LA, International Working Group on the Diabetic Foot (2001) Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diab Care 24:1442–1447CrossRef Peters EJ, Lavery LA, International Working Group on the Diabetic Foot (2001) Effectiveness of the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diab Care 24:1442–1447CrossRef
20.
go back to reference Lavery LA, Peters EJ, William JR, Murdoch DP, Hudson A, and International Working Group on the Diabetic Foot (2008) Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diab Care 31:154–156CrossRef Lavery LA, Peters EJ, William JR, Murdoch DP, Hudson A, and International Working Group on the Diabetic Foot (2008) Reevaluating the way we classify the diabetic foot: restructuring the diabetic foot risk classification system of the International Working Group on the Diabetic Foot. Diab Care 31:154–156CrossRef
21.
go back to reference Leese GP, Reed F, Green V et al (2006) Stratification of foot ulcer risk in patients with diabetes: a population based study. Int J Clin Pract 60:541–545PubMedCrossRef Leese GP, Reed F, Green V et al (2006) Stratification of foot ulcer risk in patients with diabetes: a population based study. Int J Clin Pract 60:541–545PubMedCrossRef
22.
go back to reference Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pagach LM (2003) Preventive foot care in people with diabetes—American Diabetes Association. Diab Care 26(Suppl 1):S78–S79 Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pagach LM (2003) Preventive foot care in people with diabetes—American Diabetes Association. Diab Care 26(Suppl 1):S78–S79
23.
go back to reference Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pagach LM, American Diabetes Association (2004) Preventive foot care in diabetes: American Diabetes Association. Diab Care 27(Suppl 1):S63–S64 Mayfield JA, Reiber GE, Sanders LJ, Janisse D, Pagach LM, American Diabetes Association (2004) Preventive foot care in diabetes: American Diabetes Association. Diab Care 27(Suppl 1):S63–S64
24.
go back to reference Boyko EJ, Ahroni JH, Cohen V et al (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diab Care 29:1202–1207CrossRef Boyko EJ, Ahroni JH, Cohen V et al (2006) Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diab Care 29:1202–1207CrossRef
25.
go back to reference Monteiro-Soares M, Dinis-Ribeiro M (2010) External validation and optimisation of a model for predicting foot ulcers in patients with diabetes. Diabetologia 53:1525–1533PubMedCrossRef Monteiro-Soares M, Dinis-Ribeiro M (2010) External validation and optimisation of a model for predicting foot ulcers in patients with diabetes. Diabetologia 53:1525–1533PubMedCrossRef
26.
go back to reference Armstrong DG, Hussain SK, Middleton J et al (1998) Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination? Ostomy Wound Manage 44:70–74 Armstrong DG, Hussain SK, Middleton J et al (1998) Vibration perception threshold: are multiple sites of testing superior to single site testing on diabetic foot examination? Ostomy Wound Manage 44:70–74
27.
go back to reference Stiell IG, Wells GA (1999) Methodological standards for development of clinical decision rules in emergency medicine. Ann Emerg Med 33:437–447PubMedCrossRef Stiell IG, Wells GA (1999) Methodological standards for development of clinical decision rules in emergency medicine. Ann Emerg Med 33:437–447PubMedCrossRef
28.
go back to reference Reynolds T (2001) Disease prediction models aim to guide medical decision making. Ann Intern Med 135:637–640PubMed Reynolds T (2001) Disease prediction models aim to guide medical decision making. Ann Intern Med 135:637–640PubMed
29.
go back to reference Bhatt DL, Eagle KA, Ohman M et al (2010) Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 304:E1–E8CrossRef Bhatt DL, Eagle KA, Ohman M et al (2010) Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis. JAMA 304:E1–E8CrossRef
Metadata
Title
Risk stratification systems for diabetic foot ulcers: a systematic review
Authors
M. Monteiro-Soares
E. J. Boyko
J. Ribeiro
I. Ribeiro
M. Dinis-Ribeiro
Publication date
01-05-2011
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2011
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-010-2030-3

Other articles of this Issue 5/2011

Diabetologia 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine